Abrilumab Uses, Dosage, Side Effects and more
Abrilumab is under investigation in clinical trial NCT01290042 (Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.).
| Trade Name | Abrilumab |
| Generic | Abrilumab |
| Abrilumab Other Names | Abrilumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
